NVCR Valuation
Novocure Ltd
$
11.620
- Overview
- Forecast
- Valuation
- Earnings
NVCR Relative Valuation
NVCR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NVCR is overvalued; if below, it's undervalued.
Historical Valuation
Novocure Ltd (NVCR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of 15.29. The fair price of Novocure Ltd (NVCR) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 11.34 USD , Novocure Ltd is Undervalued By Fair.
Relative Value
Fair Zone
+Inf-+Inf
Current Price：11.34
Fair
Undervalued
-6.46
PE
1Y
3Y
5Y
Trailing
Forward
-6.40
EV/EBITDA
Novocure Ltd. (NVCR) has a current EV/EBITDA of -6.40. The 5-year average EV/EBITDA is -109.92. The thresholds are as follows: Strongly Undervalued below -807.79, Undervalued between -807.79 and -458.85, Fairly Valued between 239.02 and -458.85, Overvalued between 239.02 and 587.95, and Strongly Overvalued above 587.95. The current Forward EV/EBITDA of -6.40 falls within the Historic Trend Line -Fairly Valued range.
-5.77
EV/EBIT
Novocure Ltd. (NVCR) has a current EV/EBIT of -5.77. The 5-year average EV/EBIT is -42.36. The thresholds are as follows: Strongly Undervalued below -644.33, Undervalued between -644.33 and -343.35, Fairly Valued between 258.62 and -343.35, Overvalued between 258.62 and 559.61, and Strongly Overvalued above 559.61. The current Forward EV/EBIT of -5.77 falls within the Historic Trend Line -Fairly Valued range.
1.89
PS
Novocure Ltd. (NVCR) has a current PS of 1.89. The 5-year average PS is 13.06. The thresholds are as follows: Strongly Undervalued below -6.79, Undervalued between -6.79 and 3.14, Fairly Valued between 22.99 and 3.14, Overvalued between 22.99 and 32.91, and Strongly Overvalued above 32.91. The current Forward PS of 1.89 falls within the Undervalued range.
-304.65
P/OCF
Novocure Ltd. (NVCR) has a current P/OCF of -304.65. The 5-year average P/OCF is 65.38. The thresholds are as follows: Strongly Undervalued below -870.29, Undervalued between -870.29 and -402.45, Fairly Valued between 533.21 and -402.45, Overvalued between 533.21 and 1001.04, and Strongly Overvalued above 1001.04. The current Forward P/OCF of -304.65 falls within the Historic Trend Line -Fairly Valued range.
-16.18
P/FCF
Novocure Ltd. (NVCR) has a current P/FCF of -16.18. The 5-year average P/FCF is 115.01. The thresholds are as follows: Strongly Undervalued below -268.04, Undervalued between -268.04 and -76.51, Fairly Valued between 306.54 and -76.51, Overvalued between 306.54 and 498.07, and Strongly Overvalued above 498.07. The current Forward P/FCF of -16.18 falls within the Historic Trend Line -Fairly Valued range.
Novocure Ltd (NVCR) has a current Price-to-Book (P/B) ratio of 3.57. Compared to its 3-year average P/B ratio of 9.10 , the current P/B ratio is approximately -60.74% higher. Relative to its 5-year average P/B ratio of 18.59, the current P/B ratio is about -80.78% higher. Novocure Ltd (NVCR) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -3.27%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -1.72% , the current FCF yield is about -100.00% lower.
3.63
P/B
Median3y
9.10
Median5y
18.59
-6.60
FCF Yield
Median3y
-3.27
Median5y
-1.72
Competitors Valuation Multiple
The average P/S ratio for NVCR's competitors is 4.18, providing a benchmark for relative valuation. Novocure Ltd Corp (NVCR) exhibits a P/S ratio of 1.89, which is -54.80% above the industry average. Given its robust revenue growth of 5.62%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of NVCR decreased by 40.23% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -22.20 to -25.28.
The secondary factor is the Revenue Growth, contributed 5.62%to the performance.
Overall, the performance of NVCR in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
LUNR
Intuitive Machines Inc
10.490
USD
+0.29%
AWR
American States Water Co
76.210
USD
0.00%
BOH
Bank of Hawaii Corp
67.060
USD
+2.23%
FIVN
Five9 Inc
26.200
USD
+6.55%
FOLD
Amicus Therapeutics Inc
7.190
USD
+3.01%
CPK
Chesapeake Utilities Corp
125.960
USD
+1.21%
DIOD
Diodes Inc
54.820
USD
+2.56%
ENVA
Enova International Inc
110.270
USD
+1.09%
LAUR
Laureate Education Inc
25.950
USD
-2.33%
FAQ
Is Novocure Ltd (NVCR) currently overvalued or undervalued?
Novocure Ltd (NVCR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of 15.29. The fair price of Novocure Ltd (NVCR) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 11.34 USD , Novocure Ltd is Undervalued By Fair .
What is Novocure Ltd (NVCR) fair value?
How does NVCR's valuation metrics compare to the industry average?
What is the current P/B ratio for Novocure Ltd (NVCR) as of Aug 14 2025?
What is the current FCF Yield for Novocure Ltd (NVCR) as of Aug 14 2025?
What is the current Forward P/E ratio for Novocure Ltd (NVCR) as of Aug 14 2025?